Key Takeaways
- Beyond Meat’s Q4 2025 earnings release is scheduled for Tuesday, March 31, after market close, postponed from March 25 due to identified “material weaknesses” in the company’s financial reporting controls.
- Analysts anticipate approximately $63 million in quarterly revenue, representing an 18% decline from the prior year, alongside an expected loss of $0.10 per share.
- The options market suggests extraordinary volatility, with traders anticipating a potential 30% price movement following the announcement — significantly exceeding the stock’s historical 7–10% earnings reaction.
- The company faces a Nasdaq delisting notice after shares traded under $1 for 30 consecutive business days, with a compliance deadline of August 31, 2026, potentially triggering a reverse stock split.
- Despite challenges, institutional ownership surged in Q4, with major buyers including Geode Capital (up 445%), Charles Schwab (up 497%), and Virtu (up 670%), bringing total institutional holdings to 52.48%.
Once celebrated as a pioneering force in alternative proteins, Beyond Meat now trades as a penny stock heading into what may prove to be its most scrutinized quarterly report to date.
The alternative meat producer is set to unveil its fourth quarter 2025 financial performance following Tuesday’s trading session on March 31. Initially slated for March 25, the earnings date was rescheduled after management disclosed significant deficiencies in the company’s internal financial oversight mechanisms. This postponement immediately raised investor concerns.
Consensus estimates call for quarterly sales near $63 million, though Beyond Meat has preannounced lower figures — preliminary internal data suggests Q4 revenue closer to $61 million. This shortfall versus Street expectations underscores persistent demand challenges. Annual revenue is projected to decline approximately 10% to $275 million.
The anticipated per-share loss of roughly $0.10 would represent substantial improvement from the $0.65 loss recorded in the year-ago period. This narrowing deficit stands as one of the limited positive data points investors can cite ahead of Tuesday’s release.
On March 16, Beyond Meat announced it would postpone its Form 10-K annual filing to conduct additional inventory analysis. Mizuho’s John Baumgartner, who maintains an Underperform rating with a $1 price objective, characterized this development as troubling. He emphasized weakening demand trends across primary geographic markets and highlighted intense competitive pressures facing the company’s new protein beverage category.
Wall Street sentiment remains predominantly negative. BYND currently carries six Sell ratings and two Hold recommendations from covering analysts, with a consensus target price of $1.70 — notably above current trading levels. Weiss Ratings maintained its “sell (e+)” designation in January.
Nasdaq Compliance Battle and Delisting Risk
Beyond the quarterly results, the company confronts an additional existential challenge. Beyond Meat received official notification from Nasdaq after failing to maintain the $1 minimum bid price requirement for 30 straight trading sessions. Management has until August 31, 2026, to regain compliance. Failure to meet this threshold would almost certainly necessitate a reverse stock split.
Shares have plummeted approximately 77% over the trailing twelve months. The 50-day simple moving average sits at $0.78, while the 200-day average rests at $1.28 — both substantially higher than present valuations.
Derivatives Market Points to Massive Volatility
Options activity indicates exceptional uncertainty surrounding the earnings event. Implied volatility suggests a potential 30% price swing in either direction post-announcement. This expectation is three to four times larger than Beyond Meat’s standard 7–10% post-earnings movement.
To illustrate, a 30% move from the current $0.65 price level establishes a probable range between approximately $0.46 on the downside and $0.85 on the upside. The floor of this range would position BYND perilously near its historic low of $0.50.
Interestingly, certain institutional players increased exposure during the fourth quarter. Geode Capital Management expanded its stake by 445%, Charles Schwab Investment Management by 497%, and Virtu Financial by 670%. Institutional ownership currently represents approximately 52.48% of outstanding shares.
Sell-side analysts remain largely pessimistic, citing ongoing revenue deterioration, unresolved accounting control issues, and the looming Nasdaq compliance deadline that began in early 2026.
